AMBP vs BABA

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of just 2/9, indicating significant operational and profitability concerns. Despite strong recent earnings growth and a high dividend yield, the negative Price/Book ratio, extremely high payout ratio of 500%, and deteriorating quarterly EPS trend raise serious sustainability questions. Technical indicators are deeply bearish, and insider sentiment is weak, further undermining confidence. While valuation multiples appear low relative to peers, the lack of reliable balance sheet data and inconsistent earnings performance suggest substantial hidden risks.

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.